Charles River Laboratories International (CRL) Gross Profit: 2009-2024
Historic Gross Profit for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $1.7 billion.
- Charles River Laboratories International's Gross Profit fell 2.01% to $432.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 17.39%. This contributed to the annual value of $1.7 billion for FY2024, which is 7.05% down from last year.
- According to the latest figures from FY2024, Charles River Laboratories International's Gross Profit is $1.7 billion, which was down 7.05% from $1.8 billion recorded in FY2023.
- Over the past 5 years, Charles River Laboratories International's Gross Profit peaked at $1.8 billion during FY2023, and registered a low of $1.4 billion during FY2020.
- Over the past 3 years, Charles River Laboratories International's median Gross Profit value was $1.8 billion (recorded in 2022), while the average stood at $1.8 billion.
- In the last 5 years, Charles River Laboratories International's Gross Profit rose by 22.43% in 2021 and then decreased by 7.05% in 2024.
- Yearly analysis of 5 years shows Charles River Laboratories International's Gross Profit stood at $1.4 billion in 2020, then grew by 22.43% to $1.7 billion in 2021, then rose by 7.64% to $1.8 billion in 2022, then increased by 0.04% to $1.8 billion in 2023, then fell by 7.05% to $1.7 billion in 2024.